ESC Premium Access

Renal function and use of medication preceding new-onset atrial fibrillation - results from the nationwide FinACAF study

Congress Presentation

About the speaker

Miss Heini Jyrkila

Helsinki University Hospital and University of Helsinki, Helsinki (Finland)
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Nishinomiya, JP)

Thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Miss H. Jyrkila, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The high risk patient with atrial high rate episodes (AHRE).

29 August 2021

ESC Premium Access

Atrial fibrillation and anticoagulation with cardioversion: immediate or delayed?

29 August 2021

ESC Premium Access

How to deal with bleeding complications in patients on oral anticoagulation after recent stent implantation.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk